Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities
- PMID: 22752161
- PMCID: PMC3416619
- DOI: 10.1128/AEM.00648-12
Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities
Abstract
We isolated a new lytic Pseudomonas aeruginosa phage that requires type IV pili for infection. PA1Ø has a broad bactericidal spectrum, covering Gram-positive and Gram-negative bacteria, and can eradicate biofilm cells. PA1Ø may be developed as a therapeutic agent for biofilm-related mixed infections with P. aeruginosa and Staphylococcus aureus.
Figures




Similar articles
-
Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.J Microbiol. 2011 Dec;49(6):994-9. doi: 10.1007/s12275-011-1512-4. Epub 2011 Dec 28. J Microbiol. 2011. PMID: 22203564
-
Assessment of biofilm removal capacity of a broad host range bacteriophage JHP against Pseudomonas aeruginosa.APMIS. 2017 Jun;125(6):579-584. doi: 10.1111/apm.12691. Epub 2017 Apr 18. APMIS. 2017. PMID: 28418081
-
The adsorption of Pseudomonas aeruginosa bacteriophage phiKMV is dependent on expression regulation of type IV pili genes.FEMS Microbiol Lett. 2009 Jun;296(2):210-8. doi: 10.1111/j.1574-6968.2009.01640.x. Epub 2009 May 4. FEMS Microbiol Lett. 2009. PMID: 19459952
-
Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.Adv Virus Res. 2014;88:227-78. doi: 10.1016/B978-0-12-800098-4.00005-2. Adv Virus Res. 2014. PMID: 24373314 Review.
-
Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.J Virol. 2015 Aug;89(15):7449-56. doi: 10.1128/JVI.00385-15. Epub 2015 May 13. J Virol. 2015. PMID: 25972556 Free PMC article. Review.
Cited by
-
Phage-resistant Pseudomonas aeruginosa against a novel lytic phage JJ01 exhibits hypersensitivity to colistin and reduces biofilm production.Front Microbiol. 2022 Oct 6;13:1004733. doi: 10.3389/fmicb.2022.1004733. eCollection 2022. Front Microbiol. 2022. PMID: 36274728 Free PMC article.
-
Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae.Microbiol Spectr. 2024 Jan 11;12(1):e0125823. doi: 10.1128/spectrum.01258-23. Epub 2023 Nov 29. Microbiol Spectr. 2024. PMID: 38018985 Free PMC article.
-
Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro.PLoS One. 2019 Jan 16;14(1):e0209390. doi: 10.1371/journal.pone.0209390. eCollection 2019. PLoS One. 2019. PMID: 30650088 Free PMC article.
-
Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility.mSystems. 2019 Jun 4;4(4):e00191-18. doi: 10.1128/mSystems.00191-18. mSystems. 2019. PMID: 31164451 Free PMC article.
-
Structure and replication of Pseudomonas aeruginosa phage JBD30.EMBO J. 2024 Oct;43(19):4384-4405. doi: 10.1038/s44318-024-00195-1. Epub 2024 Aug 14. EMBO J. 2024. PMID: 39143239 Free PMC article.
References
-
- Ackermann HW. 2009. Phage classification and characterization. Methods Mol. Biol. 501: 127–140 - PubMed
-
- Courchesne NM, Parisien A, Lan CQ. 2009. Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Pat. Biotechnol. 3: 37–45 - PubMed
-
- Goodman AL, et al. 2004. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev. Cell 7: 745–754 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Molecular Biology Databases